176 related articles for article (PubMed ID: 26982177)
1. Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species.
Silva DB; Rodrigues LM; Almeida AA; Oliveira KM; Grisolia AB
Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):192-9. PubMed ID: 26982177
[TBL] [Abstract][Full Text] [Related]
2. Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong
Schell WA; Jones AM; Garvey EP; Hoekstra WJ; Schotzinger RJ; Alexander BD
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956419
[TBL] [Abstract][Full Text] [Related]
3. Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
Hull CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
Antimicrob Agents Chemother; 2012 Aug; 56(8):4223-32. PubMed ID: 22615281
[TBL] [Abstract][Full Text] [Related]
4. [Azole resistance in Candida spp].
Kakeya H; Miyazaki T; Miyazaki Y; Kohno S
Nihon Ishinkin Gakkai Zasshi; 2003; 44(2):87-92. PubMed ID: 12748589
[TBL] [Abstract][Full Text] [Related]
5. Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis.
Berkow EL; Manigaba K; Parker JE; Barker KS; Kelly SL; Rogers PD
Antimicrob Agents Chemother; 2015 Oct; 59(10):5942-50. PubMed ID: 26169412
[TBL] [Abstract][Full Text] [Related]
6. Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.
Flowers SA; Colón B; Whaley SG; Schuler MA; Rogers PD
Antimicrob Agents Chemother; 2015 Jan; 59(1):450-60. PubMed ID: 25385095
[TBL] [Abstract][Full Text] [Related]
7. A CTG Clade Candida Yeast Genetically Engineered for the Genotype-Phenotype Characterization of Azole Antifungal Resistance in Human-Pathogenic Yeasts.
Accoceberry I; Rougeron A; Biteau N; Chevrel P; Fitton-Ouhabi V; Noël T
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038279
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei.
Ricardo E; Miranda IM; Faria-Ramos I; Silva RM; Rodrigues AG; Pina-Vaz C
Antimicrob Agents Chemother; 2014 Aug; 58(8):4604-11. PubMed ID: 24867987
[TBL] [Abstract][Full Text] [Related]
9. The new mutation L321F in Candida albicans ERG11 gene may be associated with fluconazole resistance.
Oliveira Carvalho V; Okay TS; Melhem MS; Walderez Szeszs M; del Negro GM
Rev Iberoam Micol; 2013; 30(3):209-12. PubMed ID: 23402828
[TBL] [Abstract][Full Text] [Related]
10. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei.
He X; Zhao M; Chen J; Wu R; Zhang J; Cui R; Jiang Y; Chen J; Cao X; Xing Y; Zhang Y; Meng J; Deng Q; Sui T
PLoS One; 2015; 10(8):e0136185. PubMed ID: 26308936
[TBL] [Abstract][Full Text] [Related]
12. Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?
Xisto MI; Caramalho RD; Rocha DA; Ferreira-Pereira A; Sartori B; Barreto-Bergter E; Junqueira ML; Lass-Flörl C; Lackner M
J Antimicrob Chemother; 2017 Apr; 72(4):988-992. PubMed ID: 28065893
[TBL] [Abstract][Full Text] [Related]
13. A New Amino Acid Substitution at G150S in Lanosterol 14-α Demethylase (Erg11 protein) in Multi-azole-resistant Trichosporon asahii.
Kushima H; Tokimatsu I; Ishii H; Kawano R; Watanabe K; Kadota JI
Med Mycol J; 2017; 58(1):E23-E28. PubMed ID: 28250360
[TBL] [Abstract][Full Text] [Related]
14. Azole-Resistant Alleles of
Vu BG; Moye-Rowley WS
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0209821. PubMed ID: 35007132
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates.
Strzelczyk JK; Slemp-Migiel A; Rother M; Gołąbek K; Wiczkowski A
Acta Biochim Pol; 2013; 60(4):547-52. PubMed ID: 24340302
[TBL] [Abstract][Full Text] [Related]
16. Limited
Healey KR; Kordalewska M; Jiménez Ortigosa C; Singh A; Berrío I; Chowdhary A; Perlin DS
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082281
[TBL] [Abstract][Full Text] [Related]
17. Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates.
Bosco-Borgeat ME; Mazza M; Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G
Rev Argent Microbiol; 2016; 48(2):137-42. PubMed ID: 27311753
[TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
19. Hotspot mutations and genomic expansion of ERG11 are major mechanisms of azole resistance in environmental and human commensal isolates of Candida tropicalis.
Hu T; Wang S; Bing J; Zheng Q; Du H; Li C; Guan Z; Bai FY; Nobile CJ; Chu H; Huang G
Int J Antimicrob Agents; 2023 Dec; 62(6):107010. PubMed ID: 37863341
[TBL] [Abstract][Full Text] [Related]
20. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
Zhang L; Yang HF; Liu YY; Xu XH; Ye Y; Li JB
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
